QualityStocksNewsBreaks Archives - Page 359 of 1387

WednesdayAug 10, 2022 12:57 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Launches Pre-Sale Orders for Green Ammonia Production System

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) has announced that, starting today, it is accepting pre-sale orders for its onsite, containerized green ammonia production systems. The company has launched a new web page (www.FuelPositive.com/pre-sales), providing an explanation of what to expect and a dedicated email address to start the sales process. Initial customers are expected to be farmers, who will use FuelPositive’s production systems to manufacture green ammonia to be used as fertilizer and ultimately to power machinery, such as tractors and other vehicles, generators and grain drying systems. “We consider opening for pre-sale orders to be an important step in our…

WednesdayAug 10, 2022 12:34 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Positive FDA Feedback Concerning Opening IND Program

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of a positive full written response from the Food and Drug Administration (“FDA”) from its pre-Investigational New Drug (“Pre-IND”) meeting regarding DehydraTECH-CBD for the treatment of hypertension. According to the update, the FDA confirmed agreement with Lexaria’s proposal to pursue a 505(b)(2) new drug application (“NDA”) regulatory pathway for its program. This is advantageous because the abbreviated pathway, as it is often described, typically enables a faster route to commercial approval than the traditional 505(b)(1) NDA pathway. “We are very pleased to have received…

WednesdayAug 10, 2022 12:27 pm

QualityStocksNewsBreaks – Odyssey Health Inc. (ODYY) Announces Positive Results from MAD Arm of Phase I Trial

Odyssey Health (OTC: ODYY), a company focused on developing unique, life-saving medical products, today announced the completion and safety findings from Cohort I of its Multi-Day Ascending Dosing (“MAD”) arm for its phase I clinical trial. The trial is administering PRV-002, Odyssey’s novel drug to treat concussion, to healthy human subjects. According to the update, MAD Cohort I subjects were dosed for five consecutive days, with the drug, PRV-002, safe and well tolerated. “As the head of drug development for the PRV-002 concussion treatment, I was very happy to see these positive safety results when dosing for multiple days,” said…

WednesdayAug 10, 2022 12:15 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Earnings Conference Call, Webcast

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, has scheduled a conference call and webcast to discuss its earnings for the first half of 2022. The call is slated for Monday, Aug. 15, 2022, at 4:30 p.m. ET. the company plans to release its financial report and numbers prior to the call. During the call, company officials will discuss the financial and operations results as well as provide an update on the company’s operations, house of brands and life sciences strategies; the event will also include time for a Q&A. An…

WednesdayAug 10, 2022 11:38 am

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) to Release Q2 2022 Financial Results, Host Conference Call

EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has announced plans to release its 2022 second quarter financial results after market close on Tuesday, Aug. 23, 2022. In addition, EverGen will hold a results and corporate update conference call at 10:00 a.m. ET on Wednesday, Aug. 24, 2022, hosted by Chief Executive Officer Chase Edgelow. Interested parties should visit https://ibn.fm/LFV9v to access the call. To view the full press release, visit https://ibn.fm/h9nAH About EverGen Infrastructure Corp. EverGen, Canada’s renewable natural gas infrastructure platform, is combating climate change and helping communities contribute to a sustainable future. EverGen…

TuesdayAug 09, 2022 1:18 pm

QualityStocksNewsBreaks – SPYR Inc. (SPYR) Launches World’s Smallest IoT Tracking Device

SPYR (OTCQB: SPYR), a diversified technology company developing products and leveraging the Internet of Things (“Iot”) for consumer use and large-scale applications and industries, and its subsidiary GeoTraq, have unveiled the Micro-Tracker(TM) Modem, the world’s smallest IoT tracking device. The new device blends miniscule size — it’s the size of a postage stamp — with unparalleled compatibility and reporting abilities. The device can be attached to or inserted inside an unlimited array of devices, assets, packages, equipment and power tools to provide location information. In addition, the Micro-Tracker features state-of-the-art technology designed to offer global connectivity along with cellular location technology; in…

TuesdayAug 09, 2022 1:11 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Preliminary Q3 Results

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced preliminary third-quarter results. According to the update, in addition to recent highlights and successes for the company and its EV programs, Mullen is in a strong financial position, with approximately $99 million in cash and cash equivalents on hand as of Aug. 8, 2022. Among the highlights, the company reported asset growth of 391% and positive working capital of $27,656,446. “It’s an exciting and pivotal time for Mullen as we continue to experience exceptional growth,” said David Michery, CEO and chairman of Mullen Automotive. “We’ve been focused on…

TuesdayAug 09, 2022 12:48 pm

QualityStocksNewsBreaks – Odyssey Health Inc.’s (ODYY) Dr. Jacob VanLandingham, Brett Favre Featured in ‘Get Authentic’ Podcast

Odyssey Health (OTC: ODYY), a company focused on developing unique, life-saving medical products, was featured in a recent episode of Get Authentic with Marques Ogden, a podcast series delivering honest, unfiltered and real-time stories from legendary athletes and industry leaders. NFL Hall of Famer Brett Favre and Dr. Jacob VanLandingham, head of drug development for Odyssey Health, joined the program, where Dr. VanLandingham discussed the unique selling proposition of Odyssey’s development pipeline. Favre also discussed the last days of his NFL career and his focus as a member of Odyssey’s sports advisory board. “My last play [in the NFL] was…

TuesdayAug 09, 2022 12:36 pm

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Board Appointment, Changes

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced the appointment of Nicole Lemerond to its board of directors, effective immediately. Lemerond is a financial executive with over 25 years of experience in investment management, private equity, investment banking and leveraged finance. Throughout her career, she has established and led health care groups at leading investment firms and has also worked at several large financial institutions, including Lehman Brothers and The Carlyle Group. Concurrent with Lemerond’s appointment, Adam Cutler has decided to transition off the board of directors. Cutler has served…

TuesdayAug 09, 2022 11:49 am

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Unveils Equity Program, Releases Q1 Financial Report

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has announced an at-the-market equity program allowing the company to issue and sell up to $35 million of common shares. According to the announcement, the shares can be sold “from time to time” through the Neo Exchange, the NYSE American LLC or any other “marketplace” upon which the shares are listed, quoted or traded, at the prevailing market price at the time of sale. The company anticipates using any proceeds from the sales of these shares for growth opportunities and working capital initiatives. In addition, Cybin…

Site Search

Company Search

Category: QualityStocksNewsBreaks